Aesther Healthcare (AEHA) Shareholders Approve Ocean Biomedical Deal

Aesther Healthcare Acquisition Corp. (NASDAQ:AEHA) announced this morning that its shareholders approved its combination with biotech firm Ocean Biomedical at a special meeting held on February 3.

The filing did not divulge redemption figures or a closing time, but the SPAC’s shares spiked to a high of $12.50 on the day of the vote before settling to a close at $11.00, above its estimated trust value of $10.20 per share. Once the deal is completed, the combined company is expected to trade on the Nasdaq under the symbol “OCEA”.

The parties announced their $345 million combination on August 31, 2022. Providence, Rhode Island-based Ocean Biomedical is developing treatments for malaria and different cancer types.